Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 10, Number 6—June 2004

Research

Antimicrobial Resistance among Campylobacter Strains, United States, 1997–2001

Amita Gupta*Comments to Author , Jennifer M. Nelson*, Timothy J. Barrett*, Robert V. Tauxe*, Shannon P. Rossiter*, Cindy R. Friedman*, Kevin W. Joyce*, Kirk E. Smith†, Timothy F. Jones‡, Marguerit A. Hawkins§, Beletshachew Shiferaw¶, James L. Beebe#, Duc J. Vugia**, Terry Rabatsky-Ehr††, James A. Benson‡‡, Timothy P. Root§§, Frederick J. Angulo*, and for the NARMS Working Group
Author affiliations: *Centers for Disease Control, Atlanta, Georgia, USA; †Minnesota Department of Health, St. Paul, Minnesota, USA; ‡Tennessee Department of Health, Nashville, Tennessee, USA; §Maryland Department of Health and Mental Hygiene, Baltimore, Maryland, USA; ¶Oregon Department of Human Services, Portland, Oregon, USA; #Colorado Department of Public Health & Environment, Denver, Colorado, USA; **California Department of Health Services, Sacramento, California, USA; ††Connecticut Department of Public Health, Hartford, Connecticut, USA; ‡‡Georgia Department of Human Services, Atlanta, Georgia, USA; §§New York State Department of Health, Albany, New York, USA

Main Article

Figure 1

Distribution of ciprofloxacin MICs among Campylobacter jejuni isolated from humans and retail chicken. A, human isolates, 1997–2001; n = 1,471. B, grocery store purchased chicken isolates, 1999; N = 62.

Figure 1. Distribution of ciprofloxacin MICs among Campylobacter jejuni isolated from humans and retail chicken. A, human isolates, 1997–2001; n = 1,471. B, grocery store purchased chicken isolates, 1999; N = 62.

Main Article

1This isolate was reported to be ciprofloxacin resistant in reference

TOP